Tissuepathology.com

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom

Erica Goodpaster — Wed, 09 Sep 2026 13:23:24 +0000

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has […]

The post Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom first appeared on Tissuepathology.com.

Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026

Erica Goodpaster — Tue, 08 Sep 2026 12:10:37 +0000

SEOUL, SOUTH KOREA, September 8, 2026 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the 2026 World Conference on Lung Cancer (WCLC 2026), to be held in Seoul, South Korea, from September 12 to 15. Across the three studies, Lunit researchers and […]

The post Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026 first appeared on Tissuepathology.com.

Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System

Erica Goodpaster — Mon, 07 Sep 2026 11:55:25 +0000

Agilent: The FDA-cleared system will strengthen Agilent’s support for digital pathology laboratories SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent’s ongoing commitment to digital pathology, broadening its portfolio to address […]

The post Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System first appeared on Tissuepathology.com.

Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows

Erica Goodpaster — Fri, 04 Sep 2026 11:32:15 +0000

Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/ — Hamamatsu Corporation and AIxMed, a developer of software for digital cytology workflows, today announced a technical collaboration to evaluate the integration of AIxMed’s ScanPilot™ with selected Hamamatsu NanoZoomer® whole-slide scanner […]

The post Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows first appeared on Tissuepathology.com.

Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems

Erica Goodpaster — Thu, 03 Sep 2026 12:53:02 +0000

Hamamatsu: New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ — Hamamatsu Photonics K.K. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD Slide scanner systems. Building on the previously […]

The post Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems first appeared on Tissuepathology.com.

Lumea: TreatmentGPS Launches Alpine Path Integration in Lumea’s Platform, Bringing AI-Powered Treatment Guidance Into Reports

Erica Goodpaster — Wed, 02 Sep 2026 12:39:17 +0000

Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ — Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a physician-built AI platform for clinical decision support and patient education, today announced the Alpine Path integration into Lumea’s software. This integration enables guideline-based treatment guidance […]

The post Lumea: TreatmentGPS Launches Alpine Path Integration in Lumea’s Platform, Bringing AI-Powered Treatment Guidance Into Reports first appeared on Tissuepathology.com.